Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 379 record(s)

Req # A-2021-001838

The JTI-Macdonald submission in response to the Health Canada consultation document “New Health-Related Labelling for Tobacco Products” dated October 2018.

Organization: Health Canada

10 page(s)
May 2022

Req # A-2021-001888

All media agreements and/or contracts regarding Public Health Canada's 11 million "Ripple Effect" advertising campaign as cited in the below media release. https://www.canada.ca/en/public-health/news/2021/05/government-of-canada-launches-new-ripple-effect-advertising-campaign-to-encourage-covid-19-vaccination.html.

Organization: Health Canada

34 page(s)
May 2022

Req # A-2021-002018

The Screening Acceptance Letter(s) from Health Canada to all & any generic drug manufacturer(s) related to all and any Abbreviated New Drug Submission(s) for the medicinal ingredient risperidone which appear(s) on the list of Generic Drug Submissions Under Review (GSUR).

Organization: Health Canada

1 page(s)
May 2022

Req # A-2021-002102

A list of all authorized clinical trial applications submitted from January 2015 to March 22, 2022.

Organization: Health Canada

2756 page(s)
May 2022

Req # A-2021-002139

For the following selection processes: 21-NHW-HECS-EA-NCR-322299, 22-NHW-ROEB-EA-NCR-327929, 21-NHW-ROEB-IA-NCR-319133a, 21-NHW-HPFB-IA-NCR-322996, 21-NHW-PMRA-EA-NCR-323294, 22-NHW-HPFB-INA-NCR-331790. The number of applicants, number of candidates invited to an exam assessment, number of candidates invited for an interview assessment, number of candidates who passed the selection interview assessment, number of candidates placed in a pool, by type of pool, number of referrals or appointments made from pool and the Volume Management strategies employed.

Organization: Health Canada

3 page(s)
May 2022

Req # A-2022-000035

Data related the Policy on COVID-19 Vaccination for the Health Canada attestations and the accommodation requests that were submitted and approved/denied.

Organization: Health Canada

1 page(s)
May 2022

Req # A-2022-000036

Access to all documentation related to authorizations, complaints, offence notices, recalls and inspections that may be held by or under the control of your agency in relation to the company 2573486 Ontario Inc. For the last 10 years.

Organization: Health Canada

12 page(s)
May 2022

Req # A-2022-000064

Asterisks appear next to a registrant's name in the Pesticide Label Database. I would like any and all information related to what they are used for and any information pertaining to them.

Organization: Health Canada

0 page(s)
May 2022

Req # A-2022-000071

The total number of COVID-19-attributed hospitalizations in Canada to April 17th, 2022, by age. The total number of those hospitalizations where the patient was treated with remdesivir to April 17th, 2022, by age. The total number of COVID-19-attributed in-hospital deaths in Canada to April 17th, 2022, by age. The total number of those deaths where the patient was treated with remdesivir to April 17th, 2022, by age.

Organization: Health Canada

0 page(s)
May 2022

Req # A-2022-000072

Correspondence relating to any abbreviated new drug submission filed since January 1, 2021 where the indication is obesity and/or chronic weight management.

Organization: Health Canada

0 page(s)
May 2022
Date modified: